CVACCureVac N.V.

Nasdaq curevac.com


$ 2.65 $ 0.13 (5.16 %)    

Wednesday, 01-May-2024 15:52:04 EDT
QQQ $ 422.58 $ -3.07 (-0.72 %)
DIA $ 378.81 $ 0.76 (0.2 %)
SPY $ 500.35 $ -1.63 (-0.32 %)
TLT $ 88.50 $ 0.65 (0.74 %)
GLD $ 213.80 $ 1.92 (0.91 %)
$ 2.65
$ 2.59
$ 2.63 x 200
$ 2.64 x 100
$ 2.56 - $ 2.70
$ 2.22 - $ 12.36
576,399
na
593.57M
$ 1.53
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 covid-19-patent-dispute-sorted-acuitas-therapeutics-and-curevac-reach-settlement-in-patent-battle

Acuitas Therapeutics settles lawsuit with CureVac over COVID-19 vaccine patents. Legal disputes unfold among biotech giants Pfi...

 leerink-partners-downgrades-curevac-to-market-perform-lowers-price-target-to-4

Leerink Partners analyst Mani Foroohar downgrades CureVac (NASDAQ:CVAC) from Outperform to Market Perform and lowers the pri...

Core News & Articles

https://www.curevac.com/en/curevac-announces-start-of-combined-phase-1-2-study-in-avian-influenza-h5n1-development-in-collabora...

 guggenheim-reiterates-neutral-on-curevac

Guggenheim analyst Evan Wang reiterates CureVac (NASDAQ:CVAC) with a Neutral.

 curevac-gsk-partner-release-data-on-influenza-vaccine-study

CureVac reveals Phase 2 interim data for its seasonal influenza vaccine in collaboration with GSK. Results show broad antigen c...

Core News & Articles

CureVac N.V. (NASDAQ:CVAC) (“CureVac”), a global biopharmaceutical company developing a new class of transformative medicines b...

 curevac-disclosed-ceo-alexander-zehnder-recently-purchased-50000-common-shares-of-curevac-stock

-SEC Filing

 why-biopharmaceutical-player-curevac-shares-are-rising-today

CureVac N.V. (NASDAQ: CVAC) shares are trading higher on Friday.

 why-compugen-shares-are-trading-higher-by-over-200-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Compugen Ltd. (NASDAQ: CGEN) shares rose sharply during Tuesday’s session after Gilead announced an agreement with t...

 why-is-covid-19-vaccine-player-curevac-stock-plummeting-today

A German court has invalidated a patent central to CureVac N.V's (NASDAQ: CVAC) lawsuit against BioNTech SE (NASDAQ: BNTX) ...

 bluebird-bio-vertex-energy-and-other-big-stocks-moving-lower-on-tuesday

U.S. stocks traded higher, with the Dow Jones index gaining around 150 points on Tuesday. Shares of bluebird bio, Inc. (NASDA...

Core News & Articles

Validity of CureVac patent EP 1 857 122 B1 denied by German Federal Patent Court after nullity action filed by BioNTech SEDecis...

Core News & Articles

- Reuters

 acuitas-challenges-curevac-in-legal-tussle-over-covid-19-vaccine-technology

Biotech company Acuitas Therapeutics has filed a lawsuit in Virginia federal court against Germany-based CureVac SE (NASDAQ: CV...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION